0

    542918

    GIANLIFE

    img img img img
    No Data Available

    Experience smart and hassle-free investing in minutes with Bajaj Broking! *T&C apply

    Gian Life Care Limited Share Price Today

    Investment Returns

    Over 1 Month -11.49% Over 3 Months -17.26% Over 6 Months -34.87% Over 1 Year -66.17%
    demotext Smart Investing Starts here ! Trade Smart with Fast Execution & Zero Account Opening Fees Invest Now

    Gian Life Care Limited fundamentals


    • Market cap (Cr) [-]
    • P/E Ratio (TTM) [-]
    • Beta [-]
    • Book Value / share [-]
    • Return on equity [-]%
    • EPS (TTM) [-]
    • Dividend yield [-]%
    • Net profit/quarter (Cr) [-]
    info icon alternate text
    • Market cap (Cr) 5.20
    • P/E Ratio (TTM) -6.86
    • Beta 0.09
    • Book Value / share 18.71
    • Return on equity 0.81%
    • EPS (TTM) 0.00
    • Dividend yield [-]%
    • Net profit/quarter (Cr) 0.12
    info icon alternate text

    Gian Life Care Limited Financials

    • Key Results
    • Key Ratios
    • Balance sheet
    • Cash Flow
    • Competition
    Open financial information
    Revenue
    Net income
    Particulars DEC 2025 (Values in Cr)
    Revenue 1.12
    Operating Expense 1.10
    Net Profit 0.12
    Net Profit Margin (%) 10.71
    Earnings Per Share (EPS) 0.12
    EBITDA 0.34
    Effective Tax Rate (%) -30.00
    Particulars SEP 2025 (Values in Cr)
    Revenue 0.66
    Operating Expense 1.25
    Net Profit -0.46
    Net Profit Margin (%) -69.69
    Earnings Per Share (EPS) -0.45
    EBITDA -0.30
    Effective Tax Rate (%) 8.00
    Particulars JUN 2025 (Values in Cr)
    Revenue 0.87
    Operating Expense 0.92
    Net Profit 0.05
    Net Profit Margin (%) 5.74
    Earnings Per Share (EPS) 0.05
    EBITDA 0.27
    Effective Tax Rate (%) 37.50
    Particulars MAR 2025 (Values in Cr)
    Revenue 1.11
    Operating Expense 1.32
    Net Profit -0.48
    Net Profit Margin (%) -43.24
    Earnings Per Share (EPS) -0.47
    EBITDA -0.25
    Effective Tax Rate (%) -4.34
    Particulars DEC 2024 (Values in Cr)
    Revenue 1.59
    Operating Expense 1.33
    Net Profit 0.38
    Net Profit Margin (%) 23.89
    Earnings Per Share (EPS) 0.37
    EBITDA 0.64
    Effective Tax Rate (%) 9.52
    Particulars MAR 2025 (Values in Cr)
    Revenue 6.63
    Operating Expense 6.58
    Net Profit 0.16
    Net Profit Margin (%) 2.41
    Earnings Per Share (EPS) 0.14
    EBITDA 1.18
    Effective Tax Rate (%) 46.66
    Particulars MAR 2024 (Values in Cr)
    Revenue 13.12
    Operating Expense 7.85
    Net Profit 4.30
    Net Profit Margin (%) 32.77
    Earnings Per Share (EPS) 4.16
    EBITDA 6.82
    Effective Tax Rate (%) 27.41
    Particulars MAR 2023 (Values in Cr)
    Revenue 11.92
    Operating Expense 10.84
    Net Profit 1.26
    Net Profit Margin (%) 10.57
    Earnings Per Share (EPS) 1.22
    EBITDA 2.72
    Effective Tax Rate (%) 29.60
    Particulars MAR 2022 (Values in Cr)
    Revenue 15.93
    Operating Expense 10.58
    Net Profit 4.37
    Net Profit Margin (%) 27.43
    Earnings Per Share (EPS) 4.23
    EBITDA 6.52
    Effective Tax Rate (%) 25.29
    Particulars MAR 2021 (Values in Cr)
    Revenue 10.46
    Operating Expense 7.99
    Net Profit 2.02
    Net Profit Margin (%) 19.31
    Earnings Per Share (EPS) 4.29
    EBITDA 3.34
    Effective Tax Rate (%) 26.90
    Particulars MAR 2025 (Values in Cr)
    Book Value / Share 18.60
    ROE % -0.21
    ROCE % 2.31
    Total Debt to Total Equity 0.28
    EBITDA Margin 18.40
    Particulars MAR 2024 (Values in Cr)
    Book Value / Share 18.64
    ROE % 24.13
    ROCE % 27.80
    Total Debt to Total Equity 0.27
    EBITDA Margin 51.98
    Particulars MAR 2023 (Values in Cr)
    Book Value / Share 14.62
    ROE % 7.27
    ROCE % 11.22
    Total Debt to Total Equity 0.23
    EBITDA Margin 21.31
    Particulars MAR 2022 (Values in Cr)
    Book Value / Share 13.56
    ROE % 31.15
    ROCE % 38.66
    Total Debt to Total Equity 0.14
    EBITDA Margin 41.24
    Particulars MAR 2025 (Values in Cr)
    Book Value / Share 19.11
    ROE % 0.81
    ROCE % 2.90
    Total Debt to Total Equity 0.23
    EBITDA Margin 18.10
    Particulars MAR 2024 (Values in Cr)
    Book Value / Share 18.97
    ROE % 24.63
    ROCE % 28.36
    Total Debt to Total Equity 0.25
    EBITDA Margin 52.13
    Particulars MAR 2023 (Values in Cr)
    Book Value / Share 14.81
    ROE % 8.59
    ROCE % 12.25
    Total Debt to Total Equity 0.23
    EBITDA Margin 22.90
    Particulars MAR 2022 (Values in Cr)
    Book Value / Share 13.57
    ROE % 36.89
    ROCE % 46.55
    Total Debt to Total Equity 0.13
    EBITDA Margin 41.24
    Particulars MAR 2021 (Values in Cr)
    Book Value / Share 20.54
    ROE % 23.35
    ROCE % 32.06
    Total Debt to Total Equity 0.12
    EBITDA Margin 32.41
    Particulars MAR 2025 (Values in Cr)
    Cash & Short Term Investments 6.95
    Total Assets 35.93
    Total Liabilities 35.93
    Total Equity 19.23
    Share Outstanding 1
    Price to Book Ratio 0.90
    Return on Assets (%) -0.10
    Return on Capital (%) -0.15
    Particulars MAR 2024 (Values in Cr)
    Cash & Short Term Investments 5.98
    Total Assets 32.63
    Total Liabilities 32.63
    Total Equity 19.27
    Share Outstanding 1
    Price to Book Ratio 1.29
    Return on Assets (%) 12.72
    Return on Capital (%) 17.19
    Particulars MAR 2023 (Values in Cr)
    Cash & Short Term Investments 5.76
    Total Assets 28.24
    Total Liabilities 28.24
    Total Equity 15.11
    Share Outstanding 1
    Price to Book Ratio 1.15
    Return on Assets (%) 3.76
    Return on Capital (%) 5.4
    Particulars MAR 2022 (Values in Cr)
    Cash & Short Term Investments 4.85
    Total Assets 23.06
    Total Liabilities 23.06
    Total Equity 14.02
    Share Outstanding 1
    Price to Book Ratio 3.06
    Return on Assets (%) 18.95
    Return on Capital (%) 27.5
    Particulars MAR 2025 (Values in Cr)
    Cash & Short Term Investments 6.94
    Total Assets 35.55
    Total Liabilities 35.55
    Total Equity 19.76
    Share Outstanding 1
    Price to Book Ratio 0.90
    Return on Assets (%) 0.43
    Return on Capital (%) 0.63
    Particulars MAR 2024 (Values in Cr)
    Cash & Short Term Investments 5.97
    Total Assets 32.07
    Total Liabilities 32.07
    Total Equity 19.61
    Share Outstanding 1
    Price to Book Ratio 1.29
    Return on Assets (%) 13.39
    Return on Capital (%) 18.06
    Particulars MAR 2023 (Values in Cr)
    Cash & Short Term Investments 5.75
    Total Assets 28.40
    Total Liabilities 28.40
    Total Equity 15.31
    Share Outstanding 1
    Price to Book Ratio 1.15
    Return on Assets (%) 4.42
    Return on Capital (%) 6.32
    Particulars MAR 2022 (Values in Cr)
    Cash & Short Term Investments 4.74
    Total Assets 23.05
    Total Liabilities 23.05
    Total Equity 14.03
    Share Outstanding 1
    Price to Book Ratio 3.06
    Return on Assets (%) 18.97
    Return on Capital (%) 27.51
    Particulars MAR 2021 (Values in Cr)
    Cash & Short Term Investments 2.51
    Total Assets 15.47
    Total Liabilities 15.47
    Total Equity 9.65
    Share Outstanding 0
    Price to Book Ratio 0.66
    Return on Assets (%) 13.03
    Return on Capital (%) 19.53
    Particulars MAR 2025 (Values in Cr)
    Net Income 0.03
    Cash from Operations 0.29
    Cash from Investing 0.25
    Cash from Financing 0.45
    Net change in Cash 0.97
    Free Cash Flow 0.30
    Particulars MAR 2024 (Values in Cr)
    Net Income 5.74
    Cash from Operations 0.71
    Cash from Investing -0.31
    Cash from Financing -0.16
    Net change in Cash 0.22
    Free Cash Flow 1.69
    Particulars MAR 2023 (Values in Cr)
    Net Income 1.59
    Cash from Operations 2.24
    Cash from Investing -0.94
    Cash from Financing -0.36
    Net change in Cash 0.91
    Free Cash Flow 3.87
    Particulars MAR 2022 (Values in Cr)
    Net Income 5.84
    Cash from Operations 6.46
    Cash from Investing -4.12
    Cash from Financing 0.67
    Net change in Cash 2.34
    Free Cash Flow 7.42
    Particulars MAR 2025 (Values in Cr)
    Net Income 0.29
    Cash from Operations 0.27
    Cash from Investing 0.23
    Cash from Financing 0.48
    Net change in Cash 0.97
    Free Cash Flow 0.28
    Particulars MAR 2024 (Values in Cr)
    Net Income 5.91
    Cash from Operations 0.76
    Cash from Investing 0.32
    Cash from Financing -0.85
    Net change in Cash 0.22
    Free Cash Flow 1.07
    Particulars MAR 2023 (Values in Cr)
    Net Income 1.78
    Cash from Operations 2.33
    Cash from Investing -0.94
    Cash from Financing -0.36
    Net change in Cash 1.00
    Free Cash Flow 3.97
    Particulars MAR 2022 (Values in Cr)
    Net Income 5.85
    Cash from Operations 6.46
    Cash from Investing -4.23
    Cash from Financing 0.67
    Net change in Cash 2.23
    Free Cash Flow 7.42
    Particulars MAR 2021 (Values in Cr)
    Net Income 2.75
    Cash from Operations 3.16
    Cash from Investing -1.09
    Cash from Financing -0.38
    Net change in Cash 1.38
    Free Cash Flow 3.59
    Company Name Price P/E P/B Market Cap 52 Week Low 52 Week High
    APOLLO HOSPITALS ENTERPRISE LT 8659.30 63.65 13.14 124507.45 6680.00 8730.60
    FORTIS MALAR HOSPITALS LIMITED 52.31 23.67 2.85 98.04 40.75 76.00
    SHREE PACETRONIX LTD. 125.25 14.95 2.63 46.96 71.00 283.15
    TRANSGENE BIOTEK LTD. 3.13 0.00 2.83 23.72 1.83 5.26
    Company Name Price P/E P/B Market Cap 52 Week Low 52 Week High
    APOLLO HOSPITALS ENTERPRISE LT 8659.30 82.94 12.49 124507.45 6680.00 8730.60
    [-] 0.0 0.0 0.0 0.0 0.0 0.0
    CHENNAI MEENAKSHI MULTISPECIAL 39.40 0.00 -9.58 29.43 30.30 57.48
    KOVAI MEDICAL CENTER & HO 5952.40 26.64 4.93 6511.93 5010.00 6725.00

    Gian Life Care Limited shareholding pattern

    Holding
    69.83%
    30.16%
    65.08%
    Name Shares Category
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)

    Gian Life Care Limited Technicals Summary

    • EMA & SMA
    • Resistance and Support
    • Delivery and Volume
    • Beta
    • Price Change Analysis
    5.00 -1.57 redarrow
    red-green-graph indicator
    15 Bearish
    1 Bullish
    • 5 Days 5.00
    • 26 Days 5.50
    • 10 Days 5.10
    • 50 Days 5.90
    • 12 Days 5.20
    • 100 Days 7.00
    • 20 Days 5.30
    • 200 Days 9.10
    5.00 PIVOT
    First Support 4.87 First Resistance 5.22 Second Support 4.65 Second Resistance 5.35 Third Support 4.52 Third Resistance 5.57
    RSI 34.96 ADX 51.16 MACD -0.29 Williams % R -70.49 Commodity Channel Index (CCI) -77.22
    Date 2026-06-29 Week 8000.00 Same Day 2843.00 Month 13908.00
    1 Year 0.09 3 Year 0.33
    Over 1 Month
    -11.49% down
    Over 1 Year
    -66.17% down
    Over 3 Months
    -17.26% down
    Over 3 Years
    -38.12% down
    Over 6 Months
    -34.87% down
    Over 5 Years
    -21.50% down

    Gian Life Care Limited Corporate Actions

    Ex-Date Ex-Bonus Ratio
    30 Mar 2022 29 Mar 2022 6:5

    Top Gainers

    Top Losers

    stock
    Trade stocks with ease

    Sign-in to trade with your demat account, or set up a new demat account for free

    Board Of Directors

    Similar stocks

    Frequently Asked Questions

    What is the Current Share Price of Gian Lifecare Ltd?

    Answer Field

    Gian Lifecare Ltd share price is for NSE ₹ 0.00 & for BSE ₹ 5.00 as on Jul 01 2026 03:28 PM.

    What is the Market Cap of Gian Lifecare Ltd Share?

    Answer Field

    The market cap of Gian Lifecare Ltd for NSE ₹ 0.00 & for BSE ₹ 5.20 as on Jul 01 2026 03:28 PM.

    What is the 52 Week High and Low of Gian Lifecare Ltd?

    Answer Field

    The 52 Week High and Low of Gian Lifecare Ltd for NSE is ₹ 0.00 and ₹ 0.00 and for BSE is ₹ 17.49 and ₹ 4.72.

    What is 1 year return for Gian Lifecare Ltd?

    Answer Field

    The 1 year returns on the stock has been -66.17%.

    What is the P/E Ratio of Gian Lifecare Ltd Share?

    Answer Field

    As on Jul 01 2026 03:28 PM the price-to-earnings (PE) ratio for Gian Lifecare Ltd share is -6.86.

    What is the PB ratio of Gian Lifecare Ltd Share?

    Answer Field

    As on Jul 01 2026 03:28 PM, the price-to-book (PB) ratio for Gian Lifecare Ltd share is 18.71.

    How to Buy Gian Lifecare Ltd Share?

    Answer Field

    You can trade in Gian Lifecare Ltd shares with Bajaj Broking by opening a demat account.

    How to Buy Gian Lifecare Ltd Share on Bajaj Broking App?

    Answer Field

    To buy Gian Lifecare Ltd shares on the Bajaj Broking app, follow these steps:

    • Login to the Bajaj Broking App

    • Click on the Search Icon

    • Search “Gian Lifecare Ltd”

    • Click on the BUY icon

    • Place a buy order specifying the desired quantity of shares.

    • Click BUY again to complete the purchase

    No results found

    close-img
    Authorise with OTP
    Enter the 4-Digit OTP sent to
    edit
    OTP expires in 00:59
    banner-icon

    Open Your Free Demat Account

    Enjoy low brokerage on delivery trades

    +91

    |

    Open Your Free Demat Account

    Enjoy low brokerage on delivery trades

    +91

    |